BACKGROUND: Street-involved youth are at high risk for experimenting with injection drug use; however, little attention has been given to identifying the factors that predict progression to on-going injecting. METHODS: Logistic regression was used to identify factors associated with progression to injecting weekly on a regular basis among a Canadian cohort of street-involved youth. RESULTS: Among our sample of 405 youth who had initiated injecting at baseline or during study observation, the median age was 22 years (interquartile range [IQR]=21-24), and 72% (293) reported becoming a regular injector at some point after their first injection experience. Of these, the majority (n=186, 63%) reported doing so within a month of initiating injection drug use. In multivariate analysis, the drug used at the first injection initiation event (opiates vs. cocaine vs. methamphetamine vs. other; all p>0.05) was not associated with progression; however, younger age at first injection (adjusted odds ratio [AOR]=1.13), a history of childhood physical abuse (AOR=1.81), prior regular use of the drug first injected (AOR=1.77), and having a sexual partner present at the first injection event (AOR=2.65) independently predicted progression to regular injecting. CONCLUSION: These data highlight how quickly youth progress to become regular injectors after experimentation. Findings indicate that addressing childhood trauma and interventions such as evidence-based youth focused addiction treatment that could prevent or delay regular non-injection drug use, may reduce progression to regular injection drug use among this population.
BACKGROUND: Street-involved youth are at high risk for experimenting with injection drug use; however, little attention has been given to identifying the factors that predict progression to on-going injecting. METHODS: Logistic regression was used to identify factors associated with progression to injecting weekly on a regular basis among a Canadian cohort of street-involved youth. RESULTS: Among our sample of 405 youth who had initiated injecting at baseline or during study observation, the median age was 22 years (interquartile range [IQR]=21-24), and 72% (293) reported becoming a regular injector at some point after their first injection experience. Of these, the majority (n=186, 63%) reported doing so within a month of initiating injection drug use. In multivariate analysis, the drug used at the first injection initiation event (opiates vs. cocaine vs. methamphetamine vs. other; all p>0.05) was not associated with progression; however, younger age at first injection (adjusted odds ratio [AOR]=1.13), a history of childhood physical abuse (AOR=1.81), prior regular use of the drug first injected (AOR=1.77), and having a sexual partner present at the first injection event (AOR=2.65) independently predicted progression to regular injecting. CONCLUSION: These data highlight how quickly youth progress to become regular injectors after experimentation. Findings indicate that addressing childhood trauma and interventions such as evidence-based youth focused addiction treatment that could prevent or delay regular non-injection drug use, may reduce progression to regular injection drug use among this population.
Authors: Laura A Novelli; Susan G Sherman; Jennifer R Havens; Steffanie A Strathdee; Marcella Sapun Journal: Drug Alcohol Depend Date: 2005-03-07 Impact factor: 4.492
Authors: Danielle C Ompad; Robin M Ikeda; Nina Shah; Crystal M Fuller; Susan Bailey; Edward Morse; Peter Kerndt; Carey Maslow; Yingfeng Wu; David Vlahov; Richard Garfein; Steffanie A Strathdee Journal: Am J Public Health Date: 2005-04 Impact factor: 9.308
Authors: Scott E Hadland; Dan Werb; Thomas Kerr; Eric Fu; Hong Wang; Julio S Montaner; Evan Wood Journal: Prev Med Date: 2012-08-28 Impact factor: 4.018
Authors: Scott E Hadland; Kora DeBeck; Thomas Kerr; Paul Nguyen; Annick Simo; Julio S Montaner; Evan Wood Journal: J Adolesc Health Date: 2014-06-09 Impact factor: 5.012
Authors: Hudson Reddon; Kora DeBeck; Maria Eugenia Socias; Huiru Dong; Evan Wood; Julio Montaner; Thomas Kerr; Michael-John Milloy Journal: Drug Alcohol Rev Date: 2018-02-12
Authors: Maryam Alavi; Tim Spelman; Gail V Matthews; Paul S Haber; Carolyn Day; Ingrid van Beek; Nick Walsh; Barbara Yeung; Julie Bruneau; Kathy Petoumenos; Kate Dolan; John M Kaldor; Gregory J Dore; Margaret Hellard; Jason Grebely Journal: Int J Drug Policy Date: 2015-05-21
Authors: Mark Phillips; Lindsey Richardson; Evan Wood; Paul Nguyen; Thomas Kerr; Kora DeBeck Journal: Subst Use Misuse Date: 2015-12-07 Impact factor: 2.164